BlackRock Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-48,890
Closed -$1.75M 2949
2014
Q4
$1.75M Buy
48,890
+4,743
+11% +$142K ﹤0.01% 1545
2014
Q3
$1.15M Buy
44,147
+7,105
+19% +$204K ﹤0.01% 1699
2014
Q2
$1.22M Sell
37,042
-44,739
-55% -$1.29M ﹤0.01% 1707
2014
Q1
$2.45M Buy
81,781
+10,338
+14% +$356K ﹤0.01% 1439
2013
Q4
$2.17M Buy
71,443
+11,086
+18% +$305K ﹤0.01% 1475
2013
Q3
$1.92M Sell
60,357
-8,119
-12% -$186K ﹤0.01% 1494
2013
Q2
$1.03M Buy
+68,476
New +$949K ﹤0.01% 1733

Other funds holding NPSP

BlackRock Group's NPSP Position: Q1 2015 in Review

BlackRock Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 48,890 shares — an estimated $1.75M sold.

BlackRock Group first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $2.45M in Q1 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • BlackRock Group reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Group sold 48,890 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.75M.
  • BlackRock Group first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Group's NPS PHARMACEUTICALS INC position peaked at $2.45M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.